Related Experiment Video
Updated: Mar 22, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.6K
Halometasone monohydrate (0.05%) in occupational contact dermatitis
Rituparna Maiti1, Chandra Sekhar Sirka2, Noel Shaju3
1Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Indian Journal of Pharmacology
|April 30, 2016
Summary
Halometasone 0.05% ointment effectively treats occupational contact dermatitis (OCD) with good safety. The study found no significant difference in halometasone efficacy between allergic and irritant OCD types.
Area of Science:
- Dermatology
- Occupational Health
- Pharmacology
Background:
- Occupational contact dermatitis (OCD) is often underreported and inadequately managed, particularly in developing nations.
- Topical corticosteroids are a primary treatment, but data on halometasone's efficacy and safety in OCD is limited.
- Comparative efficacy of halometasone in allergic versus irritant OCD subtypes is not well-established.
Purpose of the Study:
- To assess the efficacy and safety of halometasone in treating occupational contact dermatitis (OCD).
- To compare the therapeutic effects of halometasone in allergic and irritant forms of OCD.
Main Methods:
- A prospective, single-arm clinical study involving 150 OCD patients.
- Assessment of eczema severity using Investigator's Global Assessment (IGA), SCORAD index, and patient-oriented eczema measure (POEM).
- Evaluation of quality of life changes using the Dermatology Life Quality Index (DLQI) after 4 weeks of halometasone 0.05% ointment treatment.
Main Results:
- Statistically significant improvement (P < 0.001) in SCORAD, IGA, POEM, and DLQI after 4 weeks of halometasone therapy in 131 analyzed patients.
- Treatment success, defined by IGA improvement, was achieved in 87.8% of patients.
- Subgroup analysis showed no significant difference in halometasone's effect on allergic versus irritant OCD.
Conclusions:
- Halometasone demonstrates good efficacy and safety for treating occupational contact dermatitis (OCD).
- The drug's effectiveness is consistent across both allergic and irritant subtypes of OCD.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.9K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.9K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:23Inhaled Medications
970
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
970
01:24Antiasthma Drugs: Methylxanthines
2.0K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
2.0K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K